Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
BioSpace
Tue, 11/29/22 - 10:40 am
Envisagenics
artificial intelligence
Bristol Myers Squibb
R&D
Black Friday for Spectrum as FDA lung cancer rejection prompts 75% cut to R&D workforce
Fierce Biotech
Mon, 11/28/22 - 10:40 am
Spectrum Pharmaceuticals
layoffs
R&D
FDA
Pozenveo
Novo Nordisk invests $74M to boost API manufacturing for clinical trials
Fierce Biotech
Tue, 11/22/22 - 10:52 am
Novo Nordisk
clinical trials
APIs
API manufacturing
R&D
Merck KGaA outlines plan to rev up drug R&D
BioPharma Dive
Mon, 11/21/22 - 06:36 pm
Merck KGaA
drug development
R&D
Nabriva halts R&D, lays off 40% of staff in commercial-focused pivot for survival
Fierce Biotech
Fri, 11/11/22 - 10:46 am
Nabriva Therapeutics
R&D
layoffs
Sivextro
Harbour BioMed, Moderna partner on immunotherapies development
Pharmaceutical Business Review
Fri, 11/11/22 - 10:34 am
Harbour BioMed
Nana Biosciences
Moderna Therapeutics
immunotherapies
R&D
IQVIA and Clalit Health to launch prime site in Israel
Clinical Trials Arena
Fri, 11/11/22 - 10:30 am
IQVIA
Clalit Health
Israel
R&D
clinical trials
Sanofi Reaffirms Commitment to AI Drug Discovery with $1.2B Insilico Pact
BioSpace
Tue, 11/8/22 - 10:30 pm
Sanofi
artificial intelligence
Insilico
drug discovery
R&D
Sanofi Secures Access to Salipro's Protein Stabilization Tech in R&D Deal
BioSpace
Tue, 11/8/22 - 10:25 pm
Sanofi
Salipro
R&D
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Fierce Biotech
Tue, 11/1/22 - 12:09 pm
Pfizer
R&D
NASH
breast cancer
eczema
Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?
Endpoints
Tue, 11/1/22 - 11:06 am
COVID-19
vaccines
R&D
Corbevax
pandemic
EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development
Pharmaceutical Business Review
Tue, 11/1/22 - 11:01 am
EpiVax
Invravacc
CEPI
vaccines
R&D
betacoronaviruses
COVID-19
Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease
MedCity News
Tue, 11/1/22 - 10:55 am
Human Immunology Bioscience
autoimmune disease
R&D
MorphoSys
kidney disease
Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populations
BioSpace
Mon, 10/24/22 - 11:03 pm
BioMed X
Sanofi
R&D
artificial intelligence
virtual patients
First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat
Mon, 10/24/22 - 12:55 pm
tuberculosis
simulation
SIAM News
SIAM
R&D
Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA
Fierce Biotech
Sun, 10/23/22 - 06:54 pm
Altamira Therapeutics
Zilentin
R&D
biobucks
hearing loss
tinnitus
Summit makes case for changes to antibiotic R&D after sharing data from failed phase 3 trial
Fierce Biotech
Fri, 10/21/22 - 10:59 am
Summit Therapeutics
clinical trials
R&D
antibiotic
Novartis-partnered Orionis secures $55M to push cytokine program into clinic
Endpoints
Wed, 10/19/22 - 10:55 am
Orionis Biosciences
Novartis
funding
R&D
cytokines
Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure
Fierce Biotech
Mon, 10/17/22 - 10:49 am
Orion
restructuring
layoffs
R&D
Finland
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
CP WIre
Mon, 10/17/22 - 10:41 am
Bend Biosciences
CoreRx
Novaquest
CDMOs
R&D
drug manufacturing
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »